Spots Global Cancer Trial Database for treatment resistant or intolerant ph+all

Every month we try and update this database with for treatment resistant or intolerant ph+all cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Study of BMS-354825 in Subjects With CML Who Are Resistant to or Intolerant of Imatinib or Ph+All in Japan	NCT00337454	Chronic Myeloge...	Dasatinib Dasatinib Dasatinib Dasatinib Dasatinib Dasatinib	20 Years - 75 Years	Bristol-Myers Squibb

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: